Triple Combination Therapy

Triple Combination Therapy is a clinical treatment regimen that integrates three distinct pharmacological agents—typically a topical corticosteroid, a melanin synthesis inhibitor, and a pigment-dispersing agent—within a single formulation to simultaneously target multiple pathophysiological pathways in melasma, thereby enhancing therapeutic efficacy compared to monotherapy or dual-combination approaches.

2K

Publications

109.2K

Citations

12.4K

Authors

3.1K

Institutions

Publications per year

2017–2026

531

Authors

12.4K

  1. DS
    Dave Singh

    University of Manchester, United Kingdom

    15 publications · 2.5K citations

    14

    h-index

  2. JP
    Javier P. Gisbert

    Hospital Universitario de La Princesa, Spain

    15 publications · 684 citations

    14

    h-index

  3. NA
    Norio Akuta

    Toranomon Hospital, Japan

    12 publications · 551 citations

    12

    h-index

  4. FJ
    Fernando J. Martínez

    University of Michigan, United States

    12 publications · 2.5K citations

    12

    h-index

  5. AZ
    Angelo Zullo

    Ospedale Regina Margherita, Italy

    12 publications · 1K citations

    12

    h-index

1–5 of 12.4K

Venues

  1. Alimentary Pharmacology & Therapeutics

    150 publications · 7.5K citations

    52

    h-index

  2. PubMed

    Repository · 184 publications · 5.8K citations

    41

    h-index

  3. Helicobacter

    76 publications · 3.3K citations

    35

    h-index

  4. AIDS

    33 publications · 2.6K citations

    27

    h-index

  5. Transplantation

    31 publications · 2.8K citations

    26

    h-index

1–5